Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use

Arshad Jahangir; Marshall S. Stanton; Stephen C. Hammill; Win Kuang Shen

Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use

Arshad Jahangir, Marshall S. Stanton, Stephen C. Hammill, Win Kuang Shen

Cardiovascular Diseases

Research output: Contribution to journal › Review article › peer-review

Abstract

Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

Original language	English (US)
Pages (from-to)	534-557
Number of pages	24
Journal	Formulary
Volume	33
Issue number	6
State	Published - Dec 1 1998

ASJC Scopus subject areas

Pharmacology (medical)

Cite this

@article{5280f712337e42379dcc6fc3773f69a2,

title = "Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use",

abstract = "Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.",

author = "Arshad Jahangir and Stanton, {Marshall S.} and Hammill, {Stephen C.} and Shen, {Win Kuang}",

year = "1998",

month = dec,

day = "1",

language = "English (US)",

volume = "33",

pages = "534--557",

journal = "Formulary",

issn = "1082-801X",

publisher = "Advanstar Communications",

number = "6",

}

TY - JOUR

T1 - Class I and III antiarrhythmic drugs

T2 - Practical considerations for safe, effective use

AU - Jahangir, Arshad

AU - Stanton, Marshall S.

AU - Hammill, Stephen C.

AU - Shen, Win Kuang

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

AB - Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

UR - http://www.scopus.com/inward/record.url?scp=0032450430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032450430&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0032450430

SN - 1082-801X

VL - 33

SP - 534

EP - 557

JO - Formulary

JF - Formulary

IS - 6

ER -

Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this